PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-09-06

Date Title Company
06-Sep-2023 TriSalus Life Sciences Appoints Jodi Devlin as President of TriSalus Therapeutics Businesswire
06-Sep-2023 Silence Therapeutics to Participate in September Investor Conferences Businesswire
06-Sep-2023 Quince Therapeutics Appoints Dr. Charles S. Ryan as President Businesswire
06-Sep-2023 Allay Therapeutics Appoints Nicole Vitullo to Board of Directors Businesswire
06-Sep-2023 Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital Businesswire
06-Sep-2023 Precision BioSciences to Attend and Present at Upcoming September Investor Conferences Businesswire
06-Sep-2023 KSQ Therapeutics and CTMC Announce Strategic Collaboration to Accelerate the Development of Novel Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapies for the Treatment of Solid Tumors Businesswire
06-Sep-2023 L&T Technology Services participates in IAA Mobility, Munich Businesswire
06-Sep-2023 Minaris Regenerative Medicine Selects Apprentice.io's Tempo Manufacturing Execution System to Scale Commercial Production Newswire
06-Sep-2023 ICON plc to Present at the Baird Global Healthcare Conference Businesswire
06-Sep-2023 IO Biotech Announces Participation in Upcoming Investor Conferences IO Biotech
06-Sep-2023 IND for ATA-100, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), cleared to proceed by FDA Businesswire
06-Sep-2023 Transient Protein Expression Market Is Predicted To Grow At 8.2% CAGR By 2029 MARKITWIRED Latest Market Reports
06-Sep-2023 Engitix Announces Appointment of Christopher Stevenson Ph.D., as Chief Scientific Officer Engitix Ltd
06-Sep-2023 Vitestro starts largest-scale clinical trial globally for its autonomous blood drawing device, with enrolment of first patients in A.D.O.P.T. Vitestro
06-Sep-2023 Novel Molecular Design for Enhanced Efficacy and Safety in Radiotheranostics Chiba University, Japan
06-Sep-2023 Bloomsbury Genetic Therapies Announces New Program in Parkinson’s Disease Bloomsbury Genetic Therapies Limited
06-Sep-2023 AI in BioMed Economy Surpasses $2.5 Trillion in 2023, Set to Reach $6 Trillion by 2027 Global AI Ecosystem
06-Sep-2023 Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer Pleco Therapeutics
06-Sep-2023 Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin® Ligand Discovery Using Cutting-Edge AI and Molecular Modeling Techniques Navigo Proteins